Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Cas No. | 1096708-71-2 |
|---|---|
| Purity | ≥98% |
| Formula | C17H12Cl2F3N7O2S |
| Formula Wt. | 506.30 |
| IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
| Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
http://clinicaltrials.gov/show/NCT01425008
Proteasome inhibitor.
Endogenous peptide hormone, involved in cell gr...
Neurotoxin frequently used to aid in modeling P...
DNA alkylator.
Vitamin B6 derivative, antioxidant.
ITC, used as chiral agent.
5-HT1A agonist, α1-adrenergic antagonist.
Thienylbutyl ITC analog.
Triterpene saponin found in species of Panax.
Aminocoumarin; bacterial DNA gyrase inhibitor.<...
Saponin found in Bupleurum, Heteromorpha, and S...
Monoterpene; nAChR antagonist.
Non-competitive inhibitor of xanthine oxidase.<...
Na+ channel blocker.
Mineralocorticoid antagonist.
Thymidylate synthase inhibitor, potential SHMT,...
FAK inhibitor.
CDK2 inhibitor
Semi-synthetic avermectin; GABA potentiator.